TandemAI
Business Services · New York, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1501 Broadway Ste 1601, New York City, N...Phone Number
(347) 588-5205Website
www.tandemai.comRevenue
$73.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About TandemAI
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.Explore more
TandemAI Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TandemAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on TandemAI recently announced quarterly report
Check out if TandemAI is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once TandemAI has new funding data
Product Launch: Get notified when TandemAI launches new products
Check if TandemAI has recently received funding, and reach out quickly before it becomes old news!
TandemAI, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if TandemAI had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at TandemAI
Recommended Actions
Find VP level buyers at TandemAI
Find 3 more new buyers
Company Profile Activity
Activity Insights
TandemAI is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TandemAI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TandemAI.
TandemAI financials insights
Gather financial insights about TandemAI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$25M
2024
Angel/Seed
$9.5M
2025
Series A
$57M
TandemAI Tech Stack
A closer look at the technologies used by TandemAI
See more technologies
Most Recent Scoops
Funding
Funding
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Project
, according to a high-level source in Operations Management, is in the midst of initiatives related to artificial intelligence and machine learning.
Machine Learning, Artificial Intelligence, Operations
Funding
Funding
TandemAI News & Media
TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities
SHANGHAI & NEW YORK & BOSTON--(BUSINESS WIRE)--TandemAI, a company transforming drug discovery with state-of-the-art AI and physics-based technologies integrated with full wet lab capabilities, and Perpetual Medicines, which is advancing a computational design-synthesis platform for peptide drug discovery today announced the companies have merged. The combined company, to be known as TandemAI, will provide partners with an expanded range of methods and workflows for both small molecule and peptTandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
SUZHOU & SHANGHAI & NEW YORK--(BUSINESS WIRE)--TandemAI, a technology company focused on transforming drug discovery infrastructure, today announced it has raised $35 million in a Series A financing to expand its drug discovery service platform that integrates breakthrough computational tools with wet lab biophysics, medicinal chemistry, and biology. Qiming Venture Partners led the financing along with participation from OrbiMed, Eight Roads Ventures, and F Prime Capital. “Innovations continueTandemAI Announces Appointment of Alessandro Monge, Ph.D., as Chief Business Officer
SAN DIEGO & NEW YORK & SUZHOU & SHANGHAI--(BUSINESS WIRE)--TandemAI announces appointment of Alessandro Monge, Ph.D. as Chief Business OfficerTandemAI Announces Appointment of Steve Swann, Ph.D., as Chief Scientific Officer
NEW YORK & SUZHOU & SHANGHAI, China--(BUSINESS WIRE)--TandemAI today announced the appointment of Steve Swann, Ph.D., to the newly created position of Chief Scientific Officer. Dr. Swann joins TandemAI with nearly 20 years of research and research leadership experience in medicinal and computational chemistry at large and emerging pharmaceutical companies, most recently at Exscientia, where he was Vice President of Medicinal Chemistry (US). “Steve is a leader in integrating advanced computation
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TandemAI
Sign Up For FreeTo access detailed company insights
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.... Read More
